Idarucizumab dabigatran antidote: Clinical trial data

A clinical trial in 35 healthy volunteers treated with the anticoagulant Pradaxa dabigatran etexilate for 4 days showed that 1, 2 and 4 g doses of IV idarucizumab given on day 4 reversed Pradaxa-indu...